|
Mar 9
|
Here's What Analysts Are Forecasting For Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) After Its Annual Results
|
|
Mar 7
|
Xeris Biopharma Holdings Inc (XERS) Reports Robust Revenue Growth in Q4 and Full Year 2023
|
|
Mar 7
|
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q4 2023 Earnings Call Transcript
|
|
Mar 7
|
Q4 2023 Xeris Biopharma Holdings Inc Earnings Call
|
|
Mar 6
|
Xeris Biopharma (XERS) Reports Q4 Loss, Lags Revenue Estimates
|
|
Mar 6
|
Xeris Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Events
|
|
Mar 6
|
Xeris Refinances Its $150M Senior Secured Term Loan Facility With Hayfin Capital
|
|
Mar 5
|
Why Xeris (XERS) Might Surprise This Earnings Season
|
|
Feb 28
|
Xeris Biopharma to Report Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024
|
|
Jan 11
|
Xeris (XERS) Up on Licensing Deal With Amgen to Develop Tepezza
|
|
Jan 10
|
Xeris Biopharma Enters Into an Exclusive Worldwide License Agreement for Xeriject® Formulation of Teprotumumab
|
|
Dec 24
|
11 High Growth Micro-Cap Stocks to Buy
|
|
Dec 20
|
My Top Small-Cap Stock Pick for 2024 Is a Biotech With a Big Opportunity
|
|
Aug 11
|
10 Best Fast Growing Penny Stocks to Buy Now
|
|
Aug 10
|
Xeris Biopharma CEO unveils record quarterly revenue, underpinned by unique business model
|
|
Aug 8
|
I Like This Small-Cap Stock Long-Term: This Is How I'll Trade It
|
|
Aug 8
|
Stonegate Capital Partners Announces Publishing of a Thematic Report - Undervalued Growth Pharma Companies Amidst Healthcare Sector Decline
|
|
Aug 8
|
Xeris Biopharma Reports Second Quarter 2023 Financial Results
|
|
Mar 30
|
Xeris Biopharma Announces Research Evaluation Collaboration and Option Agreement With Regeneron for XeriJect™
|
|
Mar 29
|
Xeris Biopharma Appoints Ricki Fairley to Board of Directors
|